Agenda & Registration
21st ANNUAL ONCOLOGY RESEARCH & EDUCATION DAY
Best Western Plus Lamplighter Inn & Conference Centre
Crystal Ballroom, Regency Room, Chelsea Room & Atrium
591 Wellington Road, London
Thursday June 12, 2025 - 8:30AM to 5:00PM
REGISTER HERE
AGENDA
Overall Learning Objectives:
By the end of this program, participants will be able to:
1.To review contributions from different oncology disciplines, including medical oncology, radiation oncology, surgery, and medical biophysics, to a comprehensive cancer treatment approach; 2.Discuss and assess cutting-edge research in oncology, including novel methodologies for studying cancer at the cellular level and the implications for treatment resistance and patient care; 3.Appraise research findings and demonstrate how collaboration bridge clinical and basic science research in oncology.
| 7:45 |
Registration and Breakfast - Atrium Please register and enjoy a light breakfast while networking with colleagues |
| 8:30 |
Welcome and Opening Remarks - Crystal Ballroom Daniel Breadner MD. FRCPC. and Saman Maleki PhD. - Conference Co-Chairs Robert Bartha PhD – Vice Dean, Research and Innovation, Schulich School of Medicine & Dentistry John MacFarlane - President & CEO, London Health Sciences Foundation Michael Ott MD. FRCSC. - Department of Oncology Chair and Physician Executive Oncology LHSC Kirk Baines – Philanthropist & Founder, Baines Centre for Translational Cancer Research |
| 9:00-10:00 |
Morning Oral Presentation - Crystal Ballroom Judges: Alison Allan PhD - VP, Western Research, Western University Diwakar Davar MD - Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Centre Lisa Porter PhD - VP, Research and Scientific Director, St. Joseph's Health Care London |
| 9:00 | 1. Towards an Open Source Fully Automated Treatment Planning Pipeline for Multi-Target Lung Stereotactic Ablative Body Radiotherapy. Edward Wang MD/PhD Candidate |
| 9:15 | 2. Examining calcium signaling pathways in PDAC using patient-derived organoids and cancer-associated fibroblasts. Petra Samardzija PhD Candidate |
| 9:30 | 3. Unintended Immunosuppression: Antibiotic Disruption of Gut Microbiota in Mismatch Repair-Deficient Tumours. Tiffany Cheung MSc. Candidate |
| 9:45 | 4. Single cell characterization of head and neck cancer reveals the association of T cell exhaustion and cytotoxicity with disease recurrence and chemoradiation exposure. Shengjie Ying MD/PhD Candidate |
| 10:00-11:30 |
Poster Viewing and Judging (Odd Numbers) - Regency and Chelsea Conference Rooms Please enjoy refreshments and light snack - Atrium |
| 11:30-12:30 |
Keynote Lecture - Crystal Ballroom "Uncovering metagenomic signatures of response, resistance and irAE development in ICI treated melanoma." Diwakar Davar, MD. MS. Objectives:1.Understanding metagenomic signatures of response, resistance and irAE development in ICI treated melanoma, 2. Understanding that metagenomic signatures are ICI-regimen specific, 3. Using AI and ML to more accurately identify ICI-responders. |
| 12:30-1:30 |
Lunch - Crystal Ballroom & Atrium |
| 1:30-2:30 |
Afternoon Oral Presentations - Crystal Ballroom Judges: Alison Allan PhD, Diwarkar Davar MD and Lisa Porter PhD Crystal Ballroom |
| 1:30 |
5. Examining Factors Affecting Clinical Trial Enrolment in the Clinical Trials Navigator Program. Michael Touma MD, Research Assistant. |
| 1:45 | 6. Quantification of respiratory-induced errors in Stereotactic Ablative Radiotherapy for lung cancer using 4D-CT imaging. Zainab Zahra Undergraduate Student. |
| 2:00 | 7. Novel anti-angiogenic compound elicits anti-tumour lymphocyte response in peripheral blood and ascites leading to disease regression in advanced-stage epithelial ovarian cancer. Leslie Ogilvie Postdoctural Associate |
| 2:15 | 8. Impact of Stereotactic Ablative Radiotherapy (SABR) on Detection of ctDNA in Patients with Early-Stage Lung Cancer – Interim Findings from the Prospective SABR-DETECT Trial. Saurav Verma MD, Clinical Fellow. |
| 2:30-3:00 |
Panel Discussion - Enhancing Translational Research in London: Building Bridges Between Science and Medicine Moderator: Saman Maleki PhD Panelists:
Crystal Ballroom |
| 3:00-4:30 |
Poster Viewing and Judging (Even Numbers) - Regency and Chelsea Conference Rooms Please enjoy refreshments and light snack - Atrium |
| 4:30 |
Presentation of Awards - Crystal Ballroom Michael Ott - Department of Oncology, Academic Excellence Awards (5) Morgan Black - Denise Power Cancer Research Staff Award of Excellence (1) Daniel Breadner and Saman Maleki - Oral (2) and Poster Presentation Awards (10) |
| 5:00 |
Concluding Remarks and Adjournment Daniel Breadner and Saman Maleki |
*This program has received an educational grant or in-kind support from: Gold Sponsors: AstraZeneca, GSK, Lilly, Novartis. Silver Sponsors: AbbVie, Amgen, Bristol Myers Squibb, Daiichi-Sankyo AstraZeneca, EMD Serono, Eisai, Knight Therapeutics, Pfizer Oncology, Recordati Rare Diseases, Servier. Bronze Sponsors: Ipsen, Johnson & Johnson Innovative Medicine, Roche, Takeda.
